Antifungal compound process

US10421741B2 · kind B2 · utility

Assignees

• Mycovia Pharmaceuticals, Inc. · US
• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• William J. Hoekstra · Durham, US
• Christopher M. Yates · Raleigh, US
• Mark Behnke · Somerville, US
• Asaf Alimardanov · Nanuet, US
• Scott A. David · Huntsburg, US
• Douglas Franklin Fry · Euclid, US

Key dates

• Filing date: Jul 9, 2018
• Grant date: Sep 24, 2019
• Expiry date: Jul 9, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/06
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.